Drug profile

The FDA adverse-event record for Altrenogest Oily Solution

233 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Altrenogest Oily Solution. See the species affected, top reactions, and outcomes below.

233
adverse-event reports
1.3%
death-coded share
Unknown
most-reported species
66
Containers, Leaking - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
233
Total Reports
3
Deaths Reported
1.3%
Death Rate

Active Ingredients

Altrenogest Oily Solution

Administration Routes

UnknownOralTopicalIntravenousOther

Species Affected

Unknown 99
Horse 68
Human 48
Pig 12
Other Mammals 2
Other Porcine 1
Dog 1
Cat 1
Other 1

Most Affected Breeds

Unknown 151
Quarter Horse 24
Horse (unknown) 9
Thoroughbred 9
Pig (unknown) 5
Commercial hybrid 4
Crossbred Equine/horse 4
Hanovarian 4
Warmblood (unspecified) 3
Crossbred Porcine/Pig 2

Most Reported Reactions

Containers, Leaking 66
Seal, Abnormal 34
Lack of efficacy - NOS 25
Accidental exposure 20
Closure, Abnormal 20
INEFFECTIVE, ESTRUS SUPPRESSIO 17
Drug administration duration too long 16
Product problem 14
Caps, Abnormal 12
Headache 11
Mammary gland disorder NOS 11
Mammary gland oedema 10

Outcome Breakdown

Ongoing
83 (61.9%)
Outcome Unknown
27 (20.1%)
Recovered/Normal
19 (14.2%)
Recovered with Sequela
2 (1.5%)
Died
2 (1.5%)
Euthanized
1 (0.7%)

Altrenogest Oily Solution Adverse Event Insights

233 reports name Altrenogest Oily Solution; 3 recorded a death outcome (1.3% of reported events, not a population-level mortality rate). Active ingredient: Altrenogest Oily Solution. Administration routes: Unknown, Oral, Topical, Intravenous.

By species: Unknown (99 reports), Horse (68 reports), Human (48 reports). By breed: Unknown (151), Quarter Horse (24), Horse (unknown) (9).

Leading clinical signs: Containers, Leaking (66), Seal, Abnormal (34), Lack of efficacy - NOS (25), Accidental exposure (20). Outcome, 134 coded reports: Ongoing leads at 61.9%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.